Assay to measure oxidized and reduced forms of CoQ by LC-MS/MS

Methods in Molecular Biology

Volumn 837, Issue , 2012, Pages 169-179

  Hahn, Si Houn ^a,b   Kerfoot, Sandra ^a   Vasta, Valeria ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Altered redox status; CoQ; CoQ deficiency; Mitochondrial disorders; Oxidized form; Reduced form; Tandem mass spectrometry

Indexed keywords

DRUG DERIVATIVE; UBIDECARENONE; UBIQUINONE; UBIQUINONE 9;

ARTICLE; BLOOD; BLOOD ANALYSIS; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEUKOCYTE; METABOLISM; METHODOLOGY; OXIDATION REDUCTION REACTION; TANDEM MASS SPECTROMETRY;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LEUKOCYTES; OXIDATION-REDUCTION; TANDEM MASS SPECTROMETRY; UBIQUINONE;

EID: 84856364266     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-504-6_11     Document Type: Article

References (11)

1. Bentinger, M., Brismar, K., and Dallner, G. (2007) The antioxidant role of coenzyme Q, Mitochondrion 7 Suppl, S41-50. (Pubitemid 46712227)
2. Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., Wong, L. J., Cohen, B. H., and Naviaux, R. K. (2008) The in-depth evaluation of suspected mitochondrial disease, Mol Genet Metab 94, 16-37.
3. Gotz, M. E., Gerstner, A., Harth, R., Dirr, A., Janetzky, B., Kuhn, W., Riederer, P., and Gerlach, M. (2000) Altered redox state of platelet coenzyme Q10 in Parkinson's disease, J Neural Transm 107, 41-48. (Pubitemid 30077041)
4. Tang, P. H., Miles, M. V., Miles, L., Quinlan, J., Wong, B., Wenisch, A., and Bove, K. (2004) Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection, Clin Chim Acta 341, 173-184. (Pubitemid 38210329)
5. Vasta, V., Sedensky, M., Morgan, P., and Hahn, S. H. (2011) Altered redox status of coenzyme Q9 refl ects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans, Mitochondrion 11, 136-138.
6. Duncan, A. J., Heales, S. J., Mills, K., Eaton, S., Land, J. M., and Hargreaves, I. P. (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard, Clin Chem 51, 2380-2382. (Pubitemid 41692590)
7. Sacconi, S., Trevisson, E., Salviati, L., Ayme, S., Rigal, O., Redondo, A. G., Mancuso, M., Siciliano, G., Tonin, P., Angelini, C., Aure, K., Lombes, A., and Desnuelle, C. (2010) Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy, Neuromuscul Disord 20, 44-48.
8. Mollet, J., Giurgea, I., Schlemmer, D., Dallner, G., Chretien, D., Delahodde, A., Bacq, D., de Lonlay, P., Munnich, A., and Rotig, A. (2007) Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone defi-ciency and oxidative phosphorylation disorders, J. Clin. Invest. 117:765-772. (Pubitemid 46348535)
9. Lopez, L. C., Schuelke, M., Quinzii, C. M., Kanki, T., Rodenburg, R.J., Naini, A., Dimauro, S., and Hirano, M. (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet 79, 1125-1129. (Pubitemid 44853484)
10. Quizii, C., Niani, A., Salviati, L., Trevission, E., Navas, P., DiMauro, S., and Hirano, M (2006) A mutation in parahydroxybenoatepolyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 117, 765-772.
11. Ruiz-Jimenez, J., Priego-Capote, F., Mata-Granados, J. M., Quesada, J. M., and Luque de Castro, M. D. (2007) Determination of the ubiquinol-10 and ubiquinone-10 (coenzyme Q10) in human serum by liquid chromatography tandem mass spectrometry to evaluate the oxidative stress, J Chromatogr A 1175, 242-248. (Pubitemid 350193233)